Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Warner

Showing results (471-480 of 481) with videos related to

Pageof 49
Sort By:
Plos Pathogens|July 1, 2025
Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonistsMelissa D Chengalroyen, Nurudeen Oketade, Aneta Worley, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Ebiomedicine|March 24, 2022
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosisDavid A Barr, Charlotte Schutz, Avuyonke Balfour, et al.
The Lancet. Respiratory Medicine|March 25, 2024
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exerciseAnna K Coussens, Syed M A Zaidi, Brian W Allwood, et al.
Elife|August 2, 2023
Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasomeSophia Gessner, Zela Alexandria-Mae Martin, Michael A Reiche, et al.
ACS Infectious Diseases|October 12, 2016
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for TuberculosisVinayak Singh, Stefano Donini, Angela Pacitto, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Molecular Microbiology|September 29, 2016
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteriaVinayak Singh, Neeraj Dhar, János Pató, et al.
Journal of the American Chemical Society|January 5, 2023
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal InhibitionTimm O Koller, Ullrich Scheid, Teresa Kösel, et al.
ACS Infectious Diseases|March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion CharacterizationDinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Pageof 49

Showing results (471-480 of 481) with videos related to

Sort By:
Pageof 49
Plos Pathogens|July 1, 2025
Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonistsMelissa D Chengalroyen, Nurudeen Oketade, Aneta Worley, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
Ebiomedicine|March 24, 2022
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosisDavid A Barr, Charlotte Schutz, Avuyonke Balfour, et al.
The Lancet. Respiratory Medicine|March 25, 2024
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exerciseAnna K Coussens, Syed M A Zaidi, Brian W Allwood, et al.
Elife|August 2, 2023
Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasomeSophia Gessner, Zela Alexandria-Mae Martin, Michael A Reiche, et al.
ACS Infectious Diseases|October 12, 2016
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for TuberculosisVinayak Singh, Stefano Donini, Angela Pacitto, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Molecular Microbiology|September 29, 2016
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteriaVinayak Singh, Neeraj Dhar, János Pató, et al.
Journal of the American Chemical Society|January 5, 2023
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal InhibitionTimm O Koller, Ullrich Scheid, Teresa Kösel, et al.
ACS Infectious Diseases|March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion CharacterizationDinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Pageof 49